Cargando…

Genetic Variability of Hepatitis C Virus (HCV) 5’ Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin

Association between hepatitis C virus (HCV) quasispecies and treatment outcome among patients with chronic hepatitis C has been the subject of many studies. However, these studies focused mainly on viral variable regions (E1 and E2) and usually did not include human immunodeficiency virus (HIV)-posi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bukowska-Ośko, Iwona, Pawełczyk, Agnieszka, Perlejewski, Karol, Kubisa, Natalia, Caraballo Cortés, Kamila, Rosińska, Magdalena, Płoski, Rafał, Fic, Maria, Kaźmierczak, Justyna, Popiel, Marta, Ząbek, Piotr, Horban, Andrzej, Radkowski, Marek, Laskus, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416933/ https://www.ncbi.nlm.nih.gov/pubmed/25932941 http://dx.doi.org/10.1371/journal.pone.0125604

Ejemplares similares

Analysis of Genotype 1b Hepatitis C Virus IRES in Serum and Peripheral Blood Mononuclear Cells in Patients Treated with Interferon and Ribavirin
por: Bukowska-Ośko, Iwona, et al.
Publicado: (2014)

Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3(+), CD14(+) and CD19(+)
por: Pawełczyk, Agnieszka, et al.
Publicado: (2013)

Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5’ Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing
por: Caraballo Cortes, Kamila, et al.
Publicado: (2016)

Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome
por: Caraballo Cortés, Kamila, et al.
Publicado: (2014)

No evidence of West Nile virus infection among Polish patients with encephalitis
por: Jabłońska, Joanna, et al.
Publicado: (2017)

Human Pegivirus in Patients with Encephalitis of Unclear Etiology, Poland
por: Bukowska-Ośko, Iwona, et al.
Publicado: (2018)

Viral etiologies in adult patients with encephalitis in Poland: A prospective single center study
por: Popiel, Marta, et al.
Publicado: (2017)

Hepatitis C virus (HCV) genotype 1b displays higher genetic variability of hypervariable region 1 (HVR1) than genotype 3
por: Janiak, Maciej, et al.
Publicado: (2019)

Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center
por: Caraballo Cortes, Kamila, et al.
Publicado: (2018)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Erratum to: ‘The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis c outcome’
por: Jabłońska, Joanna, et al.
Publicado: (2016)

The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis c outcome
por: Jabłońska, Joanna, et al.
Publicado: (2015)

Ultradeep Pyrosequencing of Hepatitis C Virus Hypervariable Region 1 in Quasispecies Analysis
por: Caraballo Cortés, Kamila, et al.
Publicado: (2013)

Next-generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations
por: Perlejewski, Karol, et al.
Publicado: (2020)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Search for Viral Infections in Cerebrospinal Fluid From Patients With Autoimmune Encephalitis
por: Perlejewski, Karol, et al.
Publicado: (2020)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Grubczak, Kamil, et al.
Publicado: (2021)

Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection
por: Radkowski, Marek, et al.
Publicado: (2023)

Expression of programmed cell death protein 1 and T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus
por: Caraballo Cortés, Kamila, et al.
Publicado: (2019)

CD8(+) T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation
por: Osuch, Sylwia, et al.
Publicado: (2022)

Metagenomic search of viral coinfections in herpes simplex encephalitis patients
por: Perlejewski, Karol, et al.
Publicado: (2023)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
por: Kovari, Helen, et al.
Publicado: (2015)

Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics
por: Perlejewski, Karol, et al.
Publicado: (2020)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
por: de Castellarnau, Montserrat, et al.
Publicado: (2012)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients
por: Aparicio, Ester, et al.
Publicado: (2010)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Clearance of HCV by Combination Therapy of Pegylated Interferon α-2a and Ribavirin Improves Insulin Resistance
por: Kim, Hong Joo, et al.
Publicado: (2009)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
por: Vogel, M, et al.
Publicado: (2010)

Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis
por: Ahmed, Mohammed Mahmound, et al.
Publicado: (2013)

Early optic neuropathy during pegylated alfa 2-B interferon and ribavirin HCV treatment. A case report
por: Chis, Bogdan Augustin, et al.
Publicado: (2019)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ciuqv5ks4n8pc1i3g847krp499